Skip to main content
Fig. 3 | BMC Psychiatry

Fig. 3

From: Comparison and predictors of treatment adherence and remission among patients with schizophrenia treated with paliperidone palmitate or atypical oral antipsychotics in community behavioral health organizations

Fig. 3

Predictors of disease remission,a REACH-OUT (2010–2013). Abbreviations: DAI, Drug Attitude Inventory; PP-C, continuous user of paliperidone palmitate; PP-N, new user of paliperidone palmitate; REACH-OUT, Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations, Outcomes study. aMultivariable logistic mixed effects regression model for disease remission (all SCI-SR domains mild or less), adjusted for all variables shown, plus proportion of days covered (by treatment, continuous), Personal and Social Performance scale score (≥70 vs <70), general life satisfaction (QOL domain, 4–7 [mixed/satisfied] vs 1–3 [dissatisfied]), and number of outpatient visits (continuous). Odds ratios and the 95% confidence intervals included

Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us